Clinical Trial: Oral THC Reduces Nightmare Frequency and Intensity in Patients With Post-Traumatic Stress
August 20, 2026
August 20, 2026
WASHINGTON, Aug. 20 [Category: Sociological] -- The National Organization for the Reform of Marijuana Laws posted the following news release:
* * *
Clinical Trial: Oral THC Reduces Nightmare Frequency and Intensity in Patients With Post-Traumatic Stress
*
Berlin, Germany: The use of the FDA-approved THC prescription drug dronabinol reduces the frequency and intensity of nightmares in patients with post-traumatic stress disorder (PTSD), accordin . . .
* * *
Clinical Trial: Oral THC Reduces Nightmare Frequency and Intensity in Patients With Post-Traumatic Stress
*
Berlin, Germany: The use of the FDA-approved THC prescription drug dronabinol reduces the frequency and intensity of nightmares in patients with post-traumatic stress disorder (PTSD), accordin . . .